Metagenomi, Inc. (MGX) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 30 transactions totaling $13.1M, demonstrating a bullish sentiment with $13.0M in net insider flow. The most recent transaction on Dec 5, 2025 involved a sale of 1,602 shares valued at $2.8K.
No significant insider buying has been recorded for MGX in the recent period.
No significant insider selling has been recorded for MGX in the recent period.
Based on recent SEC filings, insider sentiment for MGX is bullish with an Insider Alignment Score of 100/100 and a net flow of $13.0M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Metagenomi, Inc. (MGX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading MGX stock, having executed 30 transactions in the past 90 days. The most active insider is Holdings A/s Novo (Executive), who has made 3 transactions totaling $13.0M.
Get notified when executives and directors at MGX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | Irish Jian | Executive | Sale | 1,602 | $1.77 | $2.8K | |
| Dec 5, 2025 | Wapnick Pamela | Executive | Sale | 1,576 | $1.77 | $2.8K | |
| Dec 5, 2025 | Wein Matthew | Executive | Sale | 199 | $1.77 | $352 | |
| Dec 5, 2025 | C. Thomas Brian | Executive | Sale | 3,830 | $1.77 | $6.8K | |
| Dec 1, 2025 | Wein Matthew | Executive | Award | 96,000 | $1.60 | $153.6K | |
| Dec 1, 2025 | Irish Jian | Executive | Award | 211,000 | $1.60 | $337.6K | |
| Dec 1, 2025 | Irish Jian | Executive | Award | 37,500 | $1.60 | $60.0K | |
| Dec 1, 2025 | Wapnick Pamela | Executive | Award | 120,000 | $1.60 | $192.0K | |
| Sep 5, 2025 | Wein Matthew | Executive | Sale | 199 | $1.81 | $360 | |
| Sep 5, 2025 | Irish Jian | Executive | Sale | 1,602 | $1.81 | $2.9K | |
| Sep 5, 2025 | Wapnick Pamela | Executive | Sale | 1,576 | $1.81 | $2.9K | |
| Sep 5, 2025 | C. Thomas Brian | Executive | Sale | 2,701 | $1.81 | $4.9K | |
| Sep 5, 2024 | Wapnick Pamela | Executive | Sale | 6,265 | $2.88 | $18.0K | |
| Apr 1, 2024 | C. Thomas Brian | Executive | Award | 118,992 | $N/A | $0 | |
| Apr 1, 2024 | Delaney Simren | Executive | Award | 6,931 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 2 | $13.0M | 94.3% |
Award(A) | 12 | $743.2K | 5.4% |
Sale(S) | 9 | $41.8K | 0.3% |
Conversion(C) | 7 | $0 | 0.0% |
Insiders at Metagenomi, Inc. are accumulating shares at an accelerated pace. With 11 insiders making 30 transactions totaling $13.0M in purchases versus $41.8K in sales, the net buying activity of $13.0M signals strong executive confidence. Holdings A/s Novo (Executive) leads the buying activity with $13.0M in transactions across all time.